The next phase of innovation in ADCs
28 Oct 2025As antibody drug conjugates (ADCs) evolve beyond traditional boundaries, developers face mounting complexity, from high drug-to-antibody ratios (DARs) and multispecific formats to novel payloads and delivery challenges.
Discover how emerging technologies are helping overcome scientific, manufacturing, and regulatory hurdles, ensuring innovation translates into scalable, clinically viable therapies that meet the demands of modern oncology.
Links
Tags
AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Antibody Drug Conjugates